Early versus late administration of long-acting injectable antipsychotic agents among patients with newly diagnosed schizophrenia: an analysis of a commercial claims database

This study was designed to assess healthcare resource utilization (HCRU) and costs in patients with newly diagnosed schizophrenia based on timing and context of long-acting injectable antipsychotic agent (LAI) initiation. Using claims data, patients (aged 18–40 years) with first schizophrenia diagno...

Descripción completa

Detalles Bibliográficos
Autores principales: Kane, John M., Chen, Anna, Lim, Sangtaeck, Mychaskiw, Marko A., Tian, Marc, Wang, Yitong, Suett, Mark, Rubio, Jose M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams And Wilkins 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10234320/
https://www.ncbi.nlm.nih.gov/pubmed/36752713
http://dx.doi.org/10.1097/YIC.0000000000000452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10234320/
https://www.ncbi.nlm.nih.gov/pubmed/36752713
http://dx.doi.org/10.1097/YIC.0000000000000452

Ejemplares similares